<i>In Vitro</i> Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery

• Hauptverfasser: Norhayati Mohamed Noor (VerfasserIn), Azila Abdul-Aziz (VerfasserIn), Khalid Sheikh (VerfasserIn), Satyanarayana Somavarapu (VerfasserIn), Kevin M. G. Taylor (VerfasserIn)
• Format: Buch
• Veröffentlicht: MDPI AG, 2020-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Dutasteride, licensed as an oral medicine for the treatment of benign prostatic hypoplasia, has been investigated as a treatment for androgenic alopecia. In this study, the potential for dustasteride to be delivered topically in order to reduce systemic exposure, irritation of the skin, and also cyt...